• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by UnitedHealth Group Incorporated

    7/23/24 8:33:25 PM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    FWP 1 d809300dfwp.htm FWP FWP

    Issuer Free Writing Prospectus

    Filed Pursuant to Rule 433

    Registration Statement No. 333-270279

    July 23, 2024

    UNITEDHEALTH GROUP INCORPORATED

    FINAL TERM SHEET

    Dated July 23, 2024

    $500,000,000 FLOATING RATE NOTES DUE JULY 15, 2026

    $650,000,000 4.750% NOTES DUE JULY 15, 2026

    $1,250,000,000 4.800% NOTES DUE JANUARY 15, 2030

    $1,500,000,000 4.950% NOTES DUE JANUARY 15, 2032

    $2,000,000,000 5.150% NOTES DUE JULY 15, 2034

    $1,500,000,000 5.500% NOTES DUE JULY 15, 2044

    $2,750,000,000 5.625% NOTES DUE JULY 15, 2054

    $1,850,000,000 5.750% NOTES DUE JULY 15, 2064

     

    Issuer:    UnitedHealth Group Incorporated
    Ratings (Moody’s / S&P / Fitch)*:    A2 / A+ / A
    Note Type:    SEC Registered (No. 333-270279)
    Trade Date:    July 23, 2024
    Settlement Date (T+2)**:    July 25, 2024
    Maturity Date:   

    July 15, 2026 (the “Floating Rate 2026 Notes”)

    July 15, 2026 (the “2026 Notes”)

    January 15, 2030 (the “2030 Notes”)

    January 15, 2032 (the “2032 Notes”)

    July 15, 2034 (the “2034 Notes”)

    July 15, 2044 (the “2044 Notes”)

    July 15, 2054 (the “2054 Notes”)

    July 15, 2064 (the “2064 Notes”)

    Principal Amount Offered:   

    $500,000,000 (Floating Rate 2026 Notes)

    $650,000,000 (2026 Notes)

    $1,250,000,000 (2030 Notes)

    $1,500,000,000 (2032 Notes)

    $2,000,000,000 (2034 Notes)

    $1,500,000,000 (2044 Notes)

    $2,750,000,000 (2054 Notes)

    $1,850,000,000 (2064 Notes)


    Price to Public (Issue Price):   

    100% of the Principal Amount (Floating Rate 2026 Notes)

    99.832% of the Principal Amount (2026 Notes)

    99.940% of the Principal Amount (2030 Notes)

    99.773% of the Principal Amount (2032 Notes)

    99.994% of the Principal Amount (2034 Notes)

    99.081% of the Principal Amount (2044 Notes)

    99.801% of the Principal Amount (2054 Notes)

    99.397% of the Principal Amount (2064 Notes)

    Net Proceeds (After Underwriting Discount, Before Expenses) to Issuer:

      

    $499,250,000 (99.850% of the Principal Amount) (Floating Rate 2026 Notes)

    $647,933,000 (99.682% of the Principal Amount) (2026 Notes)

    $1,244,875,000 (99.590% of the Principal Amount) (2030 Notes)

    $1,490,595,000 (99.373% of the Principal Amount) (2032 Notes)

    $1,990,880,000 (99.544% of the Principal Amount) (2034 Notes)

    $1,476,465,000 (98.431% of the Principal Amount) (2044 Notes)

    $2,723,902,500 (99.051% of the Principal Amount) (2054 Notes)

    $1,824,044,500 (98.597% of the Principal Amount) (2064 Notes)

    Interest Rate:   

    Compounded SOFR plus 0.500% (Floating Rate 2026 Notes)

    4.750% (2026 Notes)

    4.800% (2030 Notes)

    4.950% (2032 Notes)

    5.150% (2034 Notes)

    5.500% (2044 Notes)

    5.625% (2054 Notes)

    5.750% (2064 Notes)


    Interest Payment Dates:   

    January 15, April 15, July 15 and October 15, commencing October 15, 2024 (Floating Rate 2026 Notes)

    January 15 and July 15, commencing January 15, 2025 (2026 Notes)

    January 15 and July 15, commencing January 15, 2025 (2030 Notes)

    January 15 and July 15, commencing January 15, 2025 (2032 Notes)

    January 15 and July 15, commencing January 15, 2025 (2034 Notes)

    January 15 and July 15, commencing January 15, 2025 (2044 Notes)

    January 15 and July 15, commencing January 15, 2025 (2054 Notes)

    January 15 and July 15, commencing January 15, 2025 (2064 Notes)

    Regular Record Dates:   

    The 15th calendar day (whether or not a business day) immediately preceding the applicable interest payment date (Floating Rate 2026 Notes)

    January 1 and July 1 (2026 Notes)

    January 1 and July 1 (2030 Notes)

    January 1 and July 1 (2032 Notes)

    January 1 and July 1 (2034 Notes)

    January 1 and July 1 (2044 Notes)

    January 1 and July 1 (2054 Notes)

    January 1 and July 1 (2064 Notes)

    Benchmark Treasury:   

    N/A (Floating Rate 2026 Notes)

    T 4.625% due June 30, 2026 (2026 Notes)

    T 4.250% due June 30, 2029 (2030 Notes)

    T 4.250% due June 30, 2031 (2032 Notes)

    T 4.375% due May 15, 2034 (2034 Notes)

    T 4.625% due May 15, 2044 (2044 Notes)

    T 4.250% due February 15, 2054 (2054 Notes)

    T 4.250% due February 15, 2054 (2064 Notes)

    Benchmark Treasury Price / Yield:   

    N/A (Floating Rate 2026 Notes)

    100-07 3⁄4 / 4.491% (2026 Notes)

    100-12 1⁄4 / 4.163% (2030 Notes)

    100-12 / 4.187% (2032 Notes)

    100-31+ / 4.251% (2034 Notes)

    100-19+ / 4.577% (2044 Notes)

    96-03+ / 4.489% (2054 Notes)

    96-03+ / 4.489% (2064 Notes)


    Spread to Benchmark Treasury:   

    N/A (Floating Rate 2026 Notes)

    + 35 basis points (2026 Notes)

    + 65 basis points (2030 Notes)

    + 80 basis points (2032 Notes)

    + 90 basis points (2034 Notes)

    + 100 basis points (2044 Notes)

    + 115 basis points (2054 Notes)

    + 130 basis points (2064 Notes)

    Re-offer Yield:   

    N/A (Floating Rate 2026 Notes)

    4.841% (2026 Notes)

    4.813% (2030 Notes)

    4.987% (2032 Notes)

    5.151% (2034 Notes)

    5.577% (2044 Notes)

    5.639% (2054 Notes)

    5.789% (2064 Notes)

     

    Optional Redemption Provisions:   

    The Floating Rate 2026 Notes will not be redeemable prior to maturity.

     

    Make-whole call at any time at a discount rate of U.S. Treasury plus 10 basis points (2026 Notes).

     

    Prior to December 15, 2029 (one month prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 10 basis points; par call on or after December 15, 2029 (2030 Notes).

     

    Prior to November 15, 2031 (two months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after November 15, 2031 (2032 Notes).

     

    Prior to April 15, 2034 (three months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after April 15, 2034 (2034 Notes).

     

    Prior to January 15, 2044 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after January 15, 2044 (2044 Notes).

     

    Prior to January 15, 2054 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on or after January 15, 2054 (2054 Notes).

     


       Prior to January 15, 2064 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on or after January 15, 2064 (2064 Notes).
    Change of Control:    If a Change of Control Triggering Event occurs, the Company will be required to make an offer to repurchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.
    Day Count:   

    Fixed Rate Notes: 30/360

    Floating Rate 2026 Notes: Actual/360

    CUSIP / ISIN:   

    91324P FE7 / US91324PFE79 (Floating Rate 2026 Notes)

    91324P FF4 / US91324PFF45 (2026 Notes)

    91324P FG2 / US91324PFG28 (2030 Notes)

    91324P FH0 / US91324PFH01 (2032 Notes)

    91324P FJ6 / US91324PFJ66 (2034 Notes)

    91324P FK3 / US91324PFK30 (2044 Notes)

    91324P FL1 / US91324PFL13 (2054 Notes)

    91324P FM9 / US91324PFM95 (2064 Notes)

    Joint Book-Running Managers:   

    Wells Fargo Securities, LLC

    Citigroup Global Markets Inc.

    J.P. Morgan Securities LLC

    PNC Capital Markets LLC

    RBC Capital Markets, LLC

    U.S. Bancorp Investments, Inc.

     

    Barclays Capital Inc.

    BNP Paribas Securities Corp.

    BofA Securities, Inc.

    Deutsche Bank Securities Inc.

    Goldman Sachs & Co. LLC

    Mizuho Securities USA LLC

    Morgan Stanley & Co. LLC

    TD Securities (USA) LLC

    Truist Securities, Inc.

    Senior Co-Managers:   

    BNY Mellon Capital Markets, LLC

    KeyBanc Capital Markets Inc.

    Santander US Capital Markets LLC

    Scotia Capital (USA) Inc.

    SG Americas Securities, LLC

    SMBC Nikko Securities America, Inc.


    Co-Managers:   

    Bancroft Capital, LLC

    Drexel Hamilton, LLC

    Fifth Third Securities, Inc.

    Huntington Securities, Inc.

    Loop Capital Markets LLC

    Regions Securities LLC

    R. Seelaus & Co., LLC

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time.

    **

    We expect that delivery of the Notes will be made against payment therefor on or about July 25, 2024, which will be the second business day following the date of pricing of the Notes (this settlement cycle being referred to as “T+2”). Under Rule 15c6-1 of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes on any date prior to the date that is one business day preceding the settlement date will be required, by virtue of the fact that the Notes initially will settle in T+2, to specify an alternative settlement cycle at the time of any such trade to prevent a failed settlement and should consult their own advisors.

    * * *

    The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Wells Fargo Securities, LLC toll-free at (800) 645-3751, Citigroup Global Markets Inc. toll-free at (800) 831-9146, J.P. Morgan Securities LLC collect at (212) 834-4533, PNC Capital Markets LLC toll-free at (855) 881-0697, RBC Capital Markets, LLC toll-free at (866) 375-6829 or U.S. Bancorp Investments, Inc. toll-free at (877) 558-2607.

    Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.

    Get the next $UNH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    10/14/2025$406.00Buy
    Goldman
    7/31/2025$198.00Neutral → Underperform
    Robert W. Baird
    7/30/2025$400.00 → $325.00Outperform
    Oppenheimer
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    More analyst ratings

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded UnitedHealth from Buy to Hold and set a new price target of $333.00

    10/29/25 7:53:31 AM ET
    $UNH
    Medical Specialities
    Health Care

    Goldman initiated coverage on UnitedHealth with a new price target

    Goldman initiated coverage of UnitedHealth with a rating of Buy and set a new price target of $406.00

    10/14/25 8:54:29 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded UnitedHealth from Neutral to Underperform and set a new price target of $198.00

    7/31/25 7:58:50 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $UNH
    SEC Filings

    View All

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on March 17, 2026, to all shareholders of record of UNH common stock as of the close of business March 9, 2026. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health

    2/25/26 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    Impactive Capital Nominates Four Candidates to WEX Board

    Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE:WEX)

    2/9/26 8:00:00 AM ET
    $ADP
    $CLVT
    $CPAY
    Diversified Commercial Services
    Industrials
    EDP Services
    Technology

    New Report Reveals Americans Are Getting Sick More Often, Earlier in Life

    UnitedHealthcare and Health Action Council release findings to help identify and address rising health risks and make care more affordable UnitedHealthcare and Health Action Council (HAC), a nonprofit employer coalition, today released their ninth annual white paper highlighting emerging health trends linked to workforce health and affordability. Based on data from more than 225,000 HAC members with health plans administered by UnitedHealthcare, the report finds that younger generations are experiencing serious health issues earlier in life, with substantial implications for employer-sponsored health plans. As part of its commitment to creating a simpler, more supportive health care exper

    2/4/26 4:05:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Regulation FD Disclosure

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    3/9/26 4:33:13 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form S-3ASR filed by UnitedHealth Group Incorporated

    S-3ASR - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    3/2/26 4:36:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    3/2/26 9:21:03 AM ET
    $UNH
    Medical Specialities
    Health Care

    President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:47 PM ET
    $UNH
    Medical Specialities
    Health Care

    CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:45 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 12:28:22 PM ET
    $UNH
    Medical Specialities
    Health Care

    Chief Accounting Officer Roos Thomas E covered exercise/tax liability with 152 shares and was granted 2,436 shares, increasing direct ownership by 8% to 31,284 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    2/25/26 4:11:27 PM ET
    $UNH
    Medical Specialities
    Health Care

    EVP & Chief Legal Officer Zaetta Christopher R covered exercise/tax liability with 129 shares and was granted 7,084 shares, increasing direct ownership by 72% to 16,627 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    2/25/26 4:10:26 PM ET
    $UNH
    Medical Specialities
    Health Care

    Chief Executive Officer, UHC Noel Timothy John covered exercise/tax liability with 123 shares and was granted 8,855 shares, increasing direct ownership by 100% to 17,472 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    2/25/26 4:09:31 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

    5/13/25 5:59:56 PM ET
    $UNH
    Medical Specialities
    Health Care

    Charlie Baker Joins UnitedHealth Group's Board of Directors

    UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

    11/3/23 4:00:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Financials

    Live finance-specific insights

    View All

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on March 17, 2026, to all shareholders of record of UNH common stock as of the close of business March 9, 2026. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health

    2/25/26 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    Impactive Capital Nominates Four Candidates to WEX Board

    Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE:WEX)

    2/9/26 8:00:00 AM ET
    $ADP
    $CLVT
    $CPAY
    Diversified Commercial Services
    Industrials
    EDP Services
    Technology

    UnitedHealth Group Reports 2025 Results and Issues 2026 Outlook

    Full Year 2025 Revenues of $447.6 Billion Grew 12% Year-Over-Year; Earnings of $13.23 Per Share; Adjusted Earnings of $16.35 Per Share Full Year 2026 Revenue Outlook Greater Than $439.0 Billion; Earnings Outlook Greater Than $17.10 Per Share; Adjusted Earnings Greater Than $17.75 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2025/unh-reports-2025-results-and-issues-2026-outlook.pdf. UnitedHealth Group (NYSE:UNH) today reported full year and fourth quarter 2025 results and issued its 2026 outlook. This press release features multimedia. View the full

    1/27/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/13/24 5:16:09 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/24 10:05:20 AM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/23 12:39:51 PM ET
    $UNH
    Medical Specialities
    Health Care